GPT Healthcare Ltd approves Q2 FY27 results, with revenue of ₹135.62 crore and net profit of ₹15.40 crore
- Revenue rose 7.5% QoQ and 14.1% YoY; operating EBITDA margin was 19.8%.
- Net profit increased 21.0% QoQ and 45.3% YoY.
- Board declared an interim dividend of ₹1 per share; record date is November 12, 2026.
- Auditor’s limited-review conclusion was unmodified; no exceptional items were reported.